PATENT CLAIM ANALYSIS

Application Number: 15773524
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.

Claim (Index 9):
The recombinant virulence attenuated Gram-negative bacterial strain for use according to  claim 8 , wherein the recombinant virulence attenuated Gram-negative bacterial strain is selected from the group consisting of the genera  Yersinia, Escherichia, Salmonella  and  Pseudomonas , and wherein the recombinant virulence attenuated Gram-negative bacterial strain is deficient in the production of all bacterial T3SS effector proteins which are virulent toward eukaryotic cells.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15039116', '13364437', '10818071', '15565609', '09763620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7446632770374787
- 35 USC 102 Novelty (BERT): 0.5185003814719389
- Combined Prediction Score: 0.7220469874809248
- Mean Citation Score: 279.251184
- Max Citation Score: 299.61252
- Similarity Product: 219.29378975142

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test